Abbott Invests €430 Million in Irish Diabetes Operations
- Abbott's new Kilkenny facility and Donegal expansion represent a €440 million investment.
- The Kilkenny facility will be 250,000 sq. ft. and located in IDA Business and Technology Park.
- The investment will create 1,000 jobs across both sites.
- The project is supported by the Irish Government through IDA Ireland.
Investment Overview
Abbott is investing €440 million to establish a new greenfield manufacturing facility in Kilkenny and expand its operations in Donegal. This investment will create 1,000 jobs across both sites.
New Kilkenny Facility
The new 250,000 sq. ft. state-of-the-art manufacturing facility will be located in the IDA Business and Technology Park in Loughboy, Kilkenny, pending planning permission. This facility will significantly increase production capacity for Abbott's FreeStyle Libre technology for diabetes care.
Government Support
The project is supported by the Irish Government through IDA Ireland. Taoiseach Micheál Martin and Tánaiste Leo Varadkar have both expressed their support, highlighting the creation of highly-skilled jobs and the boost to regional economies.
Regional Impact
IDA Ireland Executive Director Mary Buckley emphasized the long-standing presence of Abbott in Ireland and the substantial contribution the company has made to regional economies over the past 75 years. The new investment is expected to deliver a significant economic boost to the South East Region and further develop the Donegal site.
